CDKN2A and neoplasm: Pro-tumorigenic tumors displayed upregulation of genes related to pro-tumoral processes such as adhesion or migration (NCAM1), proliferation (CDK1, TOP2A) or extensively described tumor markers (CDKN2A, MTOR), among others, while showing an impairment in immune-related functions (Figure 4C,E).